Received Jul 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Drug maladministration/administered prior to shaking the content for reconstitution; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of wrong technique in product usage process in a 90-year-old male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On 01-JUL-2025, the patient received Boostrix. On 01-JUL-2025, an unknown time after receiving Boostrix, the patient experienced wrong technique in product usage process (Verbatim: Drug maladministration/administered prior to shaking the content for reconstitution). The outcome of the wrong technique in product usage process was not applicable. Additional Information: GSK Receipt Date: 02-JUL-2025 The patient received subsequent dose of Boostrix prior to shaking the content for reconstitution within the syringe, which led wrong technique in product usage process.